Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma.
about
A method for the storage and retrieval of laboratory data on human lymphoblastoid cell lines.Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virusHuman genetic markers as tracers of tumour histogenesisRegulation of the induction of colonies in vitro by normal human lymphocytesDirect evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis.Epstein-Barr virus growth-transformed cells are converted to malignancy following transfection of a 1.3-kb CATR1 antisense construct independent of a change in the level of c-myc expression followed by a 8;14 chromosomal translocation.Burkitt's lymphoma in British adults: clinical features and response to chemotherapy.Patterns of cellular proliferation in normal and tumor cell populations.Malignant lymphomas--a conceptual understanding of morphologic diversity. A reviewCharacterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination.The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice.Incorporation into DNA of the base analog 2-aminopurine by the Epstein-Barr virus-induced DNA polymerase in vivo and in vitro.Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.Stimulation of normal lymphocytes with autologous lymphoid cell lines: properties of derived killer cells.Human spontaneous killer cells selective for tumour-derived target cells.Immunologic surface markers in non-Hodgkin's lymphomas.Classification of lymphomas.Development of vaccine strategies for the treatment of B-cell malignancies.New approaches to the classification of the lymphomata.The development of non-responsiveness to immunotherapy with monoclonal anti-idiotypic antibodies in a patient with B-CLL.Clonality switch in acute myeloid leukemia.Cell Marker Studies of Human Tumorigenesis
P2860
Q30652720-6E54C349-82B6-456F-AB9E-AB6876E3A283Q33908216-E7646976-6862-453D-B2AA-21D621A84411Q34303037-423D54DE-BACF-4458-8728-2B1FE673121DQ35043207-BE364CCB-4CEC-42DE-AC64-87868DE4A2B8Q35119129-2B4FAC9B-68B2-4012-AB1E-9E7113CEC19DQ35687432-5FE75C84-321C-4AA9-90E1-7457B9A48267Q36058971-82E9BA50-3F9B-46DA-A8F2-7AECEB68369CQ36069074-BC8721E7-576D-4442-8CB9-CA8AFEAE7A7DQ36077066-847556D6-C0E4-46AA-892E-A816CCF1288BQ36092681-145359E4-4BCF-4091-8B21-DAA301546CCFQ36092735-12920238-CA5B-4B90-94E9-5A63D1D39E05Q36341297-332E3B70-870D-49B2-993C-48C0DD235765Q36341316-C8035808-5936-43C0-AD48-C1F381F24151Q36381193-839A0FDD-CD34-43F9-88CD-6E1B37EE87E3Q37331424-B39D9902-846F-4F82-B160-50CD310E7D69Q39965286-A91A6EA1-A8DE-44EA-AAAD-60D52C314ACDQ40669355-994B2237-59B9-4B6E-867C-9F7F8297757FQ40762029-67558548-4961-4280-9135-46FFBA13B84AQ41219341-90AF8F55-0B29-4891-9EB7-A2194B759401Q41669410-A9F37D06-6564-4E81-9D47-FED41D2F8439Q42073954-5426AD52-E9F5-4A45-87DD-CA98C447B1B1Q44538882-D5002A19-E728-4D2D-9DE0-313CB7C9B2CAQ53453977-85C1A1F1-9A38-4F7E-98D3-F09D5AA2EAC6Q57386920-91318633-E98D-47CE-859B-AC7638C5A9AF
P2860
Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma.
description
1973 nî lūn-bûn
@nan
1973 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@ast
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@en
type
label
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@ast
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@en
prefLabel
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@ast
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@en
P2093
P2860
P356
P1476
Immunoglobulin and glucose-6-p ...... ar origin in Burkitt lymphoma.
@en
P2093
P2860
P304
P356
10.1084/JEM.138.1.89
P407
P577
1973-07-01T00:00:00Z